Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy van de Sande

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecules (Basel, Switzerland)|July 2, 2021
Niclosamide Is Active In Vitro against Mycetoma PathogensAbdelhalim B Mahmoud, Shereen Abd Algaffar, Wendy van de Sande, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for <i>In Vitro</i> Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against <i>Madurella mycetomatis</i>Bertrand Nyuykonge, Lukas van Amelsvoort, Kimberly Eadie, et al.
Medical Mycology|October 10, 2017
Closing the mycetoma knowledge gapWendy van de Sande, Ahmed Fahal, Sarah Abdalla Ahmed, et al.
Medical Mycology Case Reports|September 26, 2022
Encapsulated eumycetoma caused by <i>Biatriospora</i> <i>mackinnonii</i>Daniela Arteaga, Andrés Tirado-Sánchez, Denisse Vázquez-González, et al.
The Lancet. Infectious Diseases|September 1, 2004
Mycetoma caused by Madurella mycetomatis: a neglected infectious burdenAbdalla O A Ahmed, Willem van Leeuwen, Ahmed Fahal, et al.
Medical Mycology|October 10, 2017
Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatisWendy Kloezen, Florianne Parel, Roger Brüggemann, et al.
Mycoses|April 10, 2022
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazoleBertrand Nyuykonge, Wilson Lim, Lukas van Amelsvoort, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 30, 2025
The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetomaMickey Konings, Emmanuel Siddig, Kimberly Eadie, et al.
The Journal of Antimicrobial Chemotherapy|January 7, 2020
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofimWilson Lim, Kimberly Eadie, Mickey Konings, et al.
Biomedicines|July 27, 2024
Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide DerivativesJingyi Ma, Dileepkumar Veeragoni, Hindole Ghosh, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecules (Basel, Switzerland)|July 2, 2021
Niclosamide Is Active In Vitro against Mycetoma PathogensAbdelhalim B Mahmoud, Shereen Abd Algaffar, Wendy van de Sande, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for <i>In Vitro</i> Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against <i>Madurella mycetomatis</i>Bertrand Nyuykonge, Lukas van Amelsvoort, Kimberly Eadie, et al.
Medical Mycology|October 10, 2017
Closing the mycetoma knowledge gapWendy van de Sande, Ahmed Fahal, Sarah Abdalla Ahmed, et al.
Medical Mycology Case Reports|September 26, 2022
Encapsulated eumycetoma caused by <i>Biatriospora</i> <i>mackinnonii</i>Daniela Arteaga, Andrés Tirado-Sánchez, Denisse Vázquez-González, et al.
The Lancet. Infectious Diseases|September 1, 2004
Mycetoma caused by Madurella mycetomatis: a neglected infectious burdenAbdalla O A Ahmed, Willem van Leeuwen, Ahmed Fahal, et al.
Medical Mycology|October 10, 2017
Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatisWendy Kloezen, Florianne Parel, Roger Brüggemann, et al.
Mycoses|April 10, 2022
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazoleBertrand Nyuykonge, Wilson Lim, Lukas van Amelsvoort, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 30, 2025
The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetomaMickey Konings, Emmanuel Siddig, Kimberly Eadie, et al.
The Journal of Antimicrobial Chemotherapy|January 7, 2020
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofimWilson Lim, Kimberly Eadie, Mickey Konings, et al.
Biomedicines|July 27, 2024
Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide DerivativesJingyi Ma, Dileepkumar Veeragoni, Hindole Ghosh, et al.
Pageof 3